<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38393535</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2509-2723</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>GeroScience</Title><ISOAbbreviation>Geroscience</ISOAbbreviation></Journal><ArticleTitle>Molecular cross-talk between long COVID-19 and Alzheimer's disease.</ArticleTitle><Pagination><StartPage>2885</StartPage><EndPage>2899</EndPage><MedlinePgn>2885-2899</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11357-024-01096-1</ELocationID><Abstract><AbstractText>The long COVID (coronavirus disease), a multisystemic condition following severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, is one of the widespread problems. Some of its symptoms affect the nervous system and resemble symptoms of Alzheimer's disease (AD)-a neurodegenerative condition caused by the accumulation of amyloid beta and hyperphosphorylation of tau proteins. Multiple studies have found dependence between these two conditions. Patients with Alzheimer's disease have a greater risk of SARS-CoV-2 infection due to increased levels of angiotensin-converting enzyme 2 (ACE2), and the infection itself promotes amyloid beta generation which enhances the risk of AD. Also, the molecular pathways are alike-misregulations in folate-mediated one-carbon metabolism, a deficit of Cq10, and disease-associated microglia. Medical imaging in both of these diseases shows a decrease in the volume of gray matter, global brain size reduction, and hypometabolism in the parahippocampal gyrus, thalamus, and cingulate cortex. In some studies, a similar approach to applied medication can be seen, including the use of amino adamantanes and phenolic compounds of rosemary. The significance of these connections and their possible application in medical practice still needs further study but there is a possibility that they will help to better understand long COVID.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pszczo&#x142;owska</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4068-4772</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Wroc&#x142;aw Medical University, Wroc&#x142;aw, Poland. magdalena.pszczolowska@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walczak</LastName><ForeName>Kamil</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Wroc&#x142;aw Medical University, Wroc&#x142;aw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Misk&#xf3;w</LastName><ForeName>Weronika</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Wroc&#x142;aw Medical University, Wroc&#x142;aw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antosz</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Wroc&#x142;aw Medical University, Wroc&#x142;aw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batko</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Wroc&#x142;aw Medical University, Wroc&#x142;aw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karska</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinic of Psychiatry, Department of Psychiatry, Medical Department, Wroc&#x142;aw Medical University, Wroc&#x142;aw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leszek</LastName><ForeName>Jerzy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinic of Psychiatry, Department of Psychiatry, Medical Department, Wroc&#x142;aw Medical University, Wroc&#x142;aw, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Geroscience</MedlineTA><NlmUniqueID>101686284</NlmUniqueID><ISSNLinking>2509-2723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Geroscience. 2024 Oct;46(5):5393. doi: 10.1007/s11357-024-01271-4</RefSource><PMID Version="1">38977629</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">FOCM</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Microglia</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>11</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38393535</ArticleId><ArticleId IdType="pmc">PMC11009207</ArticleId><ArticleId IdType="doi">10.1007/s11357-024-01096-1</ArticleId><ArticleId IdType="pii">10.1007/s11357-024-01096-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liu N, et al. The impact of dementia on the clinical outcome of COVID-19: a systematic review and meta-analysis. J Alzheimer&#x2019;s Dis. 2020;78:1775&#x2013;1782. doi: 10.3233/JAD-201016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-201016</ArticleId><ArticleId IdType="pubmed">33285638</ArticleId></ArticleIdList></Reference><Reference><Citation>Emrani S, Arain HA, DeMarshall C, Nuriel T. APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer&#x2019;s disease: a systematic review. Alzheimers Res Ther. 2020;12:141. doi: 10.1186/s13195-020-00712-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00712-4</ArticleId><ArticleId IdType="pmc">PMC7643479</ArticleId><ArticleId IdType="pubmed">33148345</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo C-L, et al. APOE e4 genotype predicts severe COVID-19 in the UK Biobank Community Cohort. J Gerontol: Ser A. 2020;75:2231&#x2013;2232. doi: 10.1093/gerona/glaa131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glaa131</ArticleId><ArticleId IdType="pmc">PMC7314139</ArticleId><ArticleId IdType="pubmed">32451547</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F, et al. ApoE4 associated with severe COVID-19 outcomes via downregulation of ACE2 and imbalanced RAS pathway. J Transl Med. 2023;21:103. doi: 10.1186/s12967-023-03945-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-03945-7</ArticleId><ArticleId IdType="pmc">PMC9910247</ArticleId><ArticleId IdType="pubmed">36759834</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia X, Wang Y, Zheng J. COVID-19 and Alzheimer&#x2019;s disease: how one crisis worsens the other. Transl Neurodegener. 2021;10:15. doi: 10.1186/s40035-021-00237-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-021-00237-2</ArticleId><ArticleId IdType="pmc">PMC8090526</ArticleId><ArticleId IdType="pubmed">33941272</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackmon K, et al. Neurocognitive screening in patients following SARS-CoV-2 infection: tools for triage. Res Sq. 2022 doi: 10.21203/rs.3.rs-1127420/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1127420/v1</ArticleId><ArticleId IdType="pmc">PMC9338515</ArticleId><ArticleId IdType="pubmed">35907815</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565&#x2013;571. doi: 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciaccio M, et al. COVID-19 and Alzheimer&#x2019;s disease. Brain Sci. 2021;11:305. doi: 10.3390/brainsci11030305.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11030305</ArticleId><ArticleId IdType="pmc">PMC7997244</ArticleId><ArticleId IdType="pubmed">33673697</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiken S, et al. Alzheimer&#x2019;s-like signaling in brains of COVID-19 patients. Alzheimer&#x2019;s Dement. 2022;18:955&#x2013;965. doi: 10.1002/alz.12558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12558</ArticleId><ArticleId IdType="pmc">PMC9011576</ArticleId><ArticleId IdType="pubmed">35112786</ArticleId></ArticleIdList></Reference><Reference><Citation>Soscia SJ, et al. The Alzheimer&#x2019;s disease-associated amyloid &#x3b2;-protein is an antimicrobial peptide. PLoS One. 2010;5:e9505. doi: 10.1371/journal.pone.0009505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009505</ArticleId><ArticleId IdType="pmc">PMC2831066</ArticleId><ArticleId IdType="pubmed">20209079</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Q, Shults NV, Gychka SG, Harris BT, Suzuki YJ. Protein expression of angiotensin-converting enzyme 2 (ACE2) is upregulated in brains with Alzheimer's disease. Int J Mol Sci. 2021;22(4):1687. doi: 10.3390/ijms22041687.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22041687</ArticleId><ArticleId IdType="pmc">PMC7914443</ArticleId><ArticleId IdType="pubmed">33567524</ArticleId></ArticleIdList></Reference><Reference><Citation>Scialo F, et al. ACE2: the major cell entry receptor for SARS-CoV-2. Lung. 2020;198:867&#x2013;877. doi: 10.1007/s00408-020-00408-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-020-00408-4</ArticleId><ArticleId IdType="pmc">PMC7653219</ArticleId><ArticleId IdType="pubmed">33170317</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631&#x2013;637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi F, Qian S, Zhang S, Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. 2020;526:135&#x2013;140. doi: 10.1016/j.bbrc.2020.03.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.03.044</ArticleId><ArticleId IdType="pmc">PMC7156119</ArticleId><ArticleId IdType="pubmed">32199615</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghighi MM, Kakhki EG, Sato C, Ghani M, Rogaeva E. The intersection between COVID-19, the gene family of ACE2 and Alzheimer&#x2019;s disease. Neurosci Insights. 2020;15:263310552097574. doi: 10.1177/2633105520975743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2633105520975743</ArticleId><ArticleId IdType="pmc">PMC7686598</ArticleId><ArticleId IdType="pubmed">33283188</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan M, Zunt SL, Goldblatt LI. Title: Oral epithelial expression of angiotensin converting enzyme-2: implications for COVID-19 diagnosis and prognosis. 10.1101/2020.06.22.165035.</Citation></Reference><Reference><Citation>Cheng H, Wang Y, Wang G. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. J Med Virol. 2020;92:726&#x2013;730. doi: 10.1002/jmv.25785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25785</ArticleId><ArticleId IdType="pmc">PMC7317908</ArticleId><ArticleId IdType="pubmed">32221983</ArticleId></ArticleIdList></Reference><Reference><Citation>Paz Ocaranza M, et al. Counter-regulatory renin&#x2013;angiotensin system in cardiovascular disease. Nat Rev Cardiol. 2020;17:116&#x2013;129. doi: 10.1038/s41569-019-0244-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-019-0244-8</ArticleId><ArticleId IdType="pmc">PMC7097090</ArticleId><ArticleId IdType="pubmed">31427727</ArticleId></ArticleIdList></Reference><Reference><Citation>Guney C, Akar F. Epithelial and endothelial expressions of ACE2: SARS-CoV-2 entry routes. J Pharm Pharm Sci. 2021;24:84&#x2013;93. doi: 10.18433/jpps31455.</Citation><ArticleIdList><ArticleId IdType="doi">10.18433/jpps31455</ArticleId><ArticleId IdType="pubmed">33626315</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim K-H, Yang S, Kim S-H, Joo J-Y. Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer&#x2019;s disease. J Infect. 2020;81:e33&#x2013;e34. doi: 10.1016/j.jinf.2020.06.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.06.072</ArticleId><ArticleId IdType="pmc">PMC7834154</ArticleId><ArticleId IdType="pubmed">32619698</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden MR, Tyagi SC. Impaired folate-mediated one-carbon metabolism in type 2 diabetes, late-onset Alzheimer&#x2019;s disease and long COVID. Medicina (B Aires) 2021;58:16. doi: 10.3390/medicina58010016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58010016</ArticleId><ArticleId IdType="pmc">PMC8779539</ArticleId><ArticleId IdType="pubmed">35056324</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan X, Field MS, Stover PJ. Cell cycle regulation of folate-mediated one-carbon metabolism. Wiley Interdiscip Rev Syst Biol Med. 2018;10(6):e1426. 10.1002/wsbm.1426.</Citation><ArticleIdList><ArticleId IdType="pubmed">29889360</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox JT, Stover PJ. Folate-mediated one-carbon metabolism. Vitam Horm. 2008;79:1&#x2013;4410. doi: 10.1016/S0083-6729(08)00401-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0083-6729(08)00401-9</ArticleId><ArticleId IdType="pubmed">18804690</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiura A, et al. MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function. Immunity. 2022;55:65&#x2013;81.e9. doi: 10.1016/j.immuni.2021.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.10.011</ArticleId><ArticleId IdType="pmc">PMC8755618</ArticleId><ArticleId IdType="pubmed">34767747</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication. Nat Commun. 2021;12:1676. doi: 10.1038/s41467-021-21903-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21903-z</ArticleId><ArticleId IdType="pmc">PMC7960988</ArticleId><ArticleId IdType="pubmed">33723254</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden MR. Hypothesis: neuroglia activation due to increased peripheral and CNS proinflammatory cytokines/chemokines with neuroinflammation may result in long COVID. Neuroglia. 2021;2:7&#x2013;35. doi: 10.3390/neuroglia2010004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neuroglia2010004</ArticleId></ArticleIdList></Reference><Reference><Citation>Troesch B, Weber P, Mohajeri M. Potential links between impaired one-carbon metabolism due to polymorphisms, inadequate B-vitamin status, and the development of Alzheimer&#x2019;s disease. Nutrients. 2016;8:803. doi: 10.3390/nu8120803.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu8120803</ArticleId><ArticleId IdType="pmc">PMC5188458</ArticleId><ArticleId IdType="pubmed">27973419</ArticleId></ArticleIdList></Reference><Reference><Citation>Flicker L, et al. B-vitamins reduce plasma levels of beta amyloid. Neurobiol Aging. 2008;29:303&#x2013;305. doi: 10.1016/j.neurobiolaging.2006.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2006.10.007</ArticleId><ArticleId IdType="pubmed">17113685</ArticleId></ArticleIdList></Reference><Reference><Citation>Yubero D, et al. Molecular diagnosis of coenzyme Q 10 deficiency. Expert Rev Mol Diagn. 2015;15:1049&#x2013;1059. doi: 10.1586/14737159.2015.1062727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14737159.2015.1062727</ArticleId><ArticleId IdType="pubmed">26144946</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhagavan HN, Chopra RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res. 2006;40:445&#x2013;453. doi: 10.1080/10715760600617843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10715760600617843</ArticleId><ArticleId IdType="pubmed">16551570</ArticleId></ArticleIdList></Reference><Reference><Citation>Kal&#xe9;n A, Appelkvist E, Dallner G. Age-related changes in the lipid compositions of rat and human tissues. Lipids. 1989;24:579&#x2013;584. doi: 10.1007/BF02535072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02535072</ArticleId><ArticleId IdType="pubmed">2779364</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitetta L, et al. The plasma bioavailability of coenzyme Q10 absorbed from the gut and the oral mucosa. J Funct Biomater. 2018;9:73. doi: 10.3390/jfb9040073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jfb9040073</ArticleId><ArticleId IdType="pmc">PMC6306788</ArticleId><ArticleId IdType="pubmed">30558322</ArticleId></ArticleIdList></Reference><Reference><Citation>Niklowitz P, et al. Coenzyme Q10 serum concentration and redox status in European adults: influence of age, sex, and lipoprotein concentration. J Clin Biochem Nutr. 2016;58:240&#x2013;245. doi: 10.3164/jcbn.15-73.</Citation><ArticleIdList><ArticleId IdType="doi">10.3164/jcbn.15-73</ArticleId><ArticleId IdType="pmc">PMC4865593</ArticleId><ArticleId IdType="pubmed">27257350</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber C, Bysted A, H&#xf8;lmer G. Coenzyme Q10 in the diet-daily intake and relative bioavailability. Mol Aspects Med. 1997;18:251&#x2013;254. doi: 10.1016/S0098-2997(97)00003-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0098-2997(97)00003-4</ArticleId><ArticleId IdType="pubmed">9266531</ArticleId></ArticleIdList></Reference><Reference><Citation>Miles MV, et al. Plasma coenzyme Q10 reference intervals, but not redox status, are affected by gender and race in self-reported healthy adults. Clin Chim Acta. 2003;332:123&#x2013;132. doi: 10.1016/S0009-8981(03)00137-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0009-8981(03)00137-2</ArticleId><ArticleId IdType="pubmed">12763289</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini A, Festa R, Raimondo S, Pontecorvi A, Littarru GP. Hormonal influence on coenzyme Q10 levels in blood plasma. Int J Mol Sci. 2011;12:9216&#x2013;9225. doi: 10.3390/ijms12129216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms12129216</ArticleId><ArticleId IdType="pmc">PMC3257126</ArticleId><ArticleId IdType="pubmed">22272129</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlando P, et al. Effect of ubiquinol supplementation on biochemical and oxidative stress indexes after intense exercise in young athletes. Redox Rep. 2018;23:136&#x2013;145. doi: 10.1080/13510002.2018.1472924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13510002.2018.1472924</ArticleId><ArticleId IdType="pmc">PMC6748686</ArticleId><ArticleId IdType="pubmed">29734881</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefely JA, Pagliarini DJ. Biochemistry of mitochondrial coenzyme Q biosynthesis. Trends Biochem Sci. 2017;42:824&#x2013;843. doi: 10.1016/j.tibs.2017.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2017.06.008</ArticleId><ArticleId IdType="pmc">PMC5731490</ArticleId><ArticleId IdType="pubmed">28927698</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Aguilera J, Cort&#xe9;s A, Fern&#xe1;ndez-Ayala D, Navas P. Biochemical assessment of coenzyme Q10 deficiency. J Clin Med. 2017;6:27. doi: 10.3390/jcm6030027.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm6030027</ArticleId><ArticleId IdType="pmc">PMC5372996</ArticleId><ArticleId IdType="pubmed">28273876</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang PS, Chou HH, Lai TJ, Yen CH, Pan JC, Lin PT. Investigation of coenzyme Q10 status, serum amyloid-&#x3b2;, and tau protein in patients with dementia. Front Aging Neurosci. 2022;25(14):910289. 10.3389/fnagi.2022.910289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9358012</ArticleId><ArticleId IdType="pubmed">35959290</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, et al. Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia? Antioxid Redox Signal. 2013;19:1855&#x2013;1860. doi: 10.1089/ars.2013.5346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5346</ArticleId><ArticleId IdType="pubmed">23600892</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurup RK, Kurup PA. Isoprenoid pathway dysfunction in chronic fatigue syndrome. Acta Neuropsychiatr. 2003;15:266&#x2013;273. doi: 10.1034/j.1601-5215.2003.00045.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1601-5215.2003.00045.x</ArticleId><ArticleId IdType="pubmed">26983655</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, et al. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. Neuro Endocrinol Lett. 2009;30:470&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pubmed">20010505</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz BZ, Shiraishi Y, Mears CJ, Binns HJ, Taylor R. Chronic fatigue syndrome after infectious mononucleosis in adolescents. Pediatrics. 2009;124:189&#x2013;193. doi: 10.1542/peds.2008-1879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2008-1879</ArticleId><ArticleId IdType="pmc">PMC2756827</ArticleId><ArticleId IdType="pubmed">19564299</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E, Hall KH, Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 &#x2018;long-haulers&#x2019;? Chronic Dis Transl Med. 2021;7:14&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185:2452&#x2013;2468.e16. doi: 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H, et al. A unique microglia type associated with restricting development of Alzheimer&#x2019;s disease. Cell. 2017;169:1276&#x2013;1290.e17. doi: 10.1016/j.cell.2017.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.05.018</ArticleId><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;1979(352):712&#x2013;716. doi: 10.1126/science.aad8373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad8373</ArticleId><ArticleId IdType="pmc">PMC5094372</ArticleId><ArticleId IdType="pubmed">27033548</ArticleId></ArticleIdList></Reference><Reference><Citation>Ionescu M, et al. The role of endothelium in COVID-19. Int J Mol Sci. 2021;22:11920. doi: 10.3390/ijms222111920.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222111920</ArticleId><ArticleId IdType="pmc">PMC8584762</ArticleId><ArticleId IdType="pubmed">34769350</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro P, et al. Is the endothelium the missing link in the pathophysiology and treatment of COVID-19 complications? Cardiovasc Drugs Ther. 2022;36:547&#x2013;560. doi: 10.1007/s10557-021-07207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10557-021-07207-w</ArticleId><ArticleId IdType="pmc">PMC8181544</ArticleId><ArticleId IdType="pubmed">34097193</ArticleId></ArticleIdList></Reference><Reference><Citation>Triposkiadis F, Xanthopoulos A, Butler J. Cardiovascular aging and heart failure. J Am Coll Cardiol. 2019;74:804&#x2013;813. doi: 10.1016/j.jacc.2019.06.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.06.053</ArticleId><ArticleId IdType="pubmed">31395131</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Lucio J, et al. Imbalance between endothelial damage and repair capacity in chronic obstructive pulmonary disease. PLoS One. 2018;13:e0195724. doi: 10.1371/journal.pone.0195724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0195724</ArticleId><ArticleId IdType="pmc">PMC5908268</ArticleId><ArticleId IdType="pubmed">29672621</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadaun PK, Chatterjee S. COVID-19 and dys-regulation of pulmonary endothelium: implications for vascular remodeling. Cytokine Growth Factor Rev. 2022;63:69&#x2013;77. doi: 10.1016/j.cytogfr.2021.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2021.10.003</ArticleId><ArticleId IdType="pmc">PMC9611904</ArticleId><ArticleId IdType="pubmed">34728151</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomo M, et al. Up-regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotide. J Cell Mol Med. 2020;24:1713&#x2013;1723. doi: 10.1111/jcmm.14865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.14865</ArticleId><ArticleId IdType="pmc">PMC6991634</ArticleId><ArticleId IdType="pubmed">31782253</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586&#x2013;590. doi: 10.1007/s00134-020-05985-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05985-9</ArticleId><ArticleId IdType="pmc">PMC7079879</ArticleId><ArticleId IdType="pubmed">32125455</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Casta&#xf1;o AB, et al. Circulating biomarkers of COVID-19-triggered endotheliopathy: from conjecture to certainty. Blood. 2020;136:31&#x2013;32. doi: 10.1182/blood-2020-142311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2020-142311</ArticleId></ArticleIdList></Reference><Reference><Citation>Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18:684&#x2013;696. doi: 10.1016/S1474-4422(19)30079-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30079-1</ArticleId><ArticleId IdType="pubmed">31097385</ArticleId></ArticleIdList></Reference><Reference><Citation>Katusic ZS, d&#x2019;Uscio LV, He T. Emerging roles of endothelial nitric oxide in preservation of cognitive health. Stroke. 2023;54:686&#x2013;696. doi: 10.1161/STROKEAHA.122.041444.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.122.041444</ArticleId><ArticleId IdType="pmc">PMC9991080</ArticleId><ArticleId IdType="pubmed">36848426</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80:844&#x2013;866. doi: 10.1016/j.neuron.2013.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.10.008</ArticleId><ArticleId IdType="pmc">PMC3842016</ArticleId><ArticleId IdType="pubmed">24267647</ArticleId></ArticleIdList></Reference><Reference><Citation>Armulik A, et al. Pericytes regulate the blood&#x2013;brain barrier. Nature. 2010;468:557&#x2013;561. doi: 10.1038/nature09522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09522</ArticleId><ArticleId IdType="pubmed">20944627</ArticleId></ArticleIdList></Reference><Reference><Citation>Galea I. The blood&#x2013;brain barrier in systemic infection and inflammation. Cell Mol Immunol. 2021;18:2489&#x2013;2501. doi: 10.1038/s41423-021-00757-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00757-x</ArticleId><ArticleId IdType="pmc">PMC8481764</ArticleId><ArticleId IdType="pubmed">34594000</ArticleId></ArticleIdList></Reference><Reference><Citation>Low A, Mak E, Rowe JB, Markus HS, O&#x2019;Brien JT. Inflammation and cerebral small vessel disease: a systematic review. Ageing Res Rev. 2019;53:100916. doi: 10.1016/j.arr.2019.100916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2019.100916</ArticleId><ArticleId IdType="pubmed">31181331</ArticleId></ArticleIdList></Reference><Reference><Citation>Grochowski C, Litak J, Kamieniak P, Maciejewski R. Oxidative stress in cerebral small vessel disease. Role of reactive species. Free Radic Res. 2018;52:1&#x2013;13. doi: 10.1080/10715762.2017.1402304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10715762.2017.1402304</ArticleId><ArticleId IdType="pubmed">29166803</ArticleId></ArticleIdList></Reference><Reference><Citation>Litak J, et al. Cerebral small vessel disease. Int J Mol Sci. 2020;21:9729. doi: 10.3390/ijms21249729.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21249729</ArticleId><ArticleId IdType="pmc">PMC7766314</ArticleId><ArticleId IdType="pubmed">33419271</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Heide FCT, van Sloten TT, Willekens N, Stehouwer CDA. Neurovascular coupling unit dysfunction and dementia: Retinal measurements as tools to move towards population-based evidence. Front Endocrinol (Lausanne). 2022;23(13):1014287. doi: 10.3389/fendo.2022.1014287.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.1014287</ArticleId><ArticleId IdType="pmc">PMC9727310</ArticleId><ArticleId IdType="pubmed">36506058</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretti R, Caruso P. Small vessel disease-related dementia: an invalid neurovascular coupling? Int J Mol Sci. 2020;21:1095. doi: 10.3390/ijms21031095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21031095</ArticleId><ArticleId IdType="pmc">PMC7036993</ArticleId><ArticleId IdType="pubmed">32046035</ArticleId></ArticleIdList></Reference><Reference><Citation>Parodi-Rull&#xe1;n RM, Javadov S, Fossati S. Dissecting the crosstalk between endothelial mitochondrial damage, vascular inflammation, and neurodegeneration in cerebral amyloid angiopathy and Alzheimer&#x2019;s disease. Cells. 2021;10:2903. doi: 10.3390/cells10112903.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10112903</ArticleId><ArticleId IdType="pmc">PMC8616424</ArticleId><ArticleId IdType="pubmed">34831125</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz MAF, Neves PFMD, Lima SS, Lopes JDC, Torres MKDS, Vallinoto IMVC, Bichara CDA, Dos Santos EF, de Brito MTFM, da Silva ALS, Leite MM, da Costa FP, Viana MNDSA, Rodrigues FBB, de Sarges KML, Cantanhede MHD, da Silva R, Bichara CNC, van den Berg AVS, et al. Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome. Front Cell Infect Microbiol. 2022;30(12):922422. 10.3389/fcimb.2022.922422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9279918</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif ZA, Gomez CR, Connors TJ, Henrich TJ, Reeves WB. Mechanistic Pathway Task RECOVER, Force. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC). Elife. 2023;22(12):e86002. 10.7554/eLife.86002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman MM, Hasan M, Ahmed A. Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients. Rev Med Virol. 2021;31:1&#x2013;12. doi: 10.1002/rmv.2213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2213</ArticleId><ArticleId IdType="pmc">PMC8014495</ArticleId><ArticleId IdType="pubmed">33426683</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini L, et al. SARS-CoV-2 infects the brain choroid plexus and disrupts the blood-CSF barrier in human brain organoids. Cell Stem Cell. 2020;27:951&#x2013;961.e5. doi: 10.1016/j.stem.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7553118</ArticleId><ArticleId IdType="pubmed">33113348</ArticleId></ArticleIdList></Reference><Reference><Citation>Flannery P, Yang I, Keyvani M, Sakoulas G. Acute psychosis due to anti-N-methyl D-aspartate receptor encephalitis following COVID-19 vaccination: A case report. Front Neurol. 2021;4(12):764197. 10.3389/fneur.2021.764197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8599934</ArticleId><ArticleId IdType="pubmed">34803896</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff MC, et al. Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID. Nat Commun. 2023;14:4201. doi: 10.1038/s41467-023-40012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-40012-7</ArticleId><ArticleId IdType="pmc">PMC10349085</ArticleId><ArticleId IdType="pubmed">37452024</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou E, et al. Endothelial dysfunction in acute and long standing COVID&#x2212;19: a prospective cohort study. Vascul Pharmacol. 2022;144:106975. doi: 10.1016/j.vph.2022.106975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2022.106975</ArticleId><ArticleId IdType="pmc">PMC8893931</ArticleId><ArticleId IdType="pubmed">35248780</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltr&#xe1;n-Camacho L, et al. The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo. Mol Med. 2022;28:40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8994070</ArticleId><ArticleId IdType="pubmed">35397534</ArticleId></ArticleIdList></Reference><Reference><Citation>Etter MM, et al. Severe neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study. Nat Commun. 2022;13:6777. doi: 10.1038/s41467-022-34068-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34068-0</ArticleId><ArticleId IdType="pmc">PMC9645766</ArticleId><ArticleId IdType="pubmed">36351919</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Francisco EB, Yogendra R, Long E, Pise A, Rodrigues H, Hall E, Herrera M, Parikh P, Guevara-Coto J, Triche TJ, Scott P, Hekmati S, Maglinte D, Chang X, Mora-Rodr&#xed;guez RA, Mora J. Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. Front Immunol. 2022;12:746021. 10.3389/fimmu.2021.746021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer&#x2019;s disease and other disorders. Nat Rev Neurosci. 2011;12:723&#x2013;738. doi: 10.1038/nrn3114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3114</ArticleId><ArticleId IdType="pmc">PMC4036520</ArticleId><ArticleId IdType="pubmed">22048062</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapasi A, Schneider JA. Vascular contributions to cognitive impairment, clinical Alzheimer&#x2019;s disease, and dementia in older persons. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2016;1862:878&#x2013;886. doi: 10.1016/j.bbadis.2015.12.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2015.12.023</ArticleId><ArticleId IdType="pmc">PMC11062590</ArticleId><ArticleId IdType="pubmed">26769363</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes-Canteli M, Iadecola C. Alzheimer&#x2019;s disease and vascular aging. J Am Coll Cardiol. 2020;75:942&#x2013;951. doi: 10.1016/j.jacc.2019.10.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.10.062</ArticleId><ArticleId IdType="pmc">PMC8046164</ArticleId><ArticleId IdType="pubmed">32130930</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada M, Naiki H. Cerebral amyloid angiopathy. Prog Mol Biol Transl Sci. 2012;107:41&#x2013;78. doi: 10.1016/B978-0-12-385883-2.00006-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-385883-2.00006-0</ArticleId><ArticleId IdType="pubmed">22482447</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EE. Cerebral amyloid angiopathy as a cause of neurodegeneration. J Neurochem. 2018;144:651&#x2013;658. doi: 10.1111/jnc.14157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14157</ArticleId><ArticleId IdType="pubmed">28833176</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanini G, et al. Vascular &#x201c;long COVID&#x201d;: a new vessel disease? Angiology. 2024;75:8&#x2013;14. doi: 10.1177/00033197231153204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00033197231153204</ArticleId><ArticleId IdType="pmc">PMC9895315</ArticleId><ArticleId IdType="pubmed">36652923</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689&#x2013;701. doi: 10.1016/S1474-4422(10)70104-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70104-6</ArticleId><ArticleId IdType="pubmed">20610345</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens CD, et al. Cerebral small vessel disease pathology in COVID-19 patients: a systematic review. Ageing Res Rev. 2023;88:101962. doi: 10.1016/j.arr.2023.101962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2023.101962</ArticleId><ArticleId IdType="pmc">PMC10202464</ArticleId><ArticleId IdType="pubmed">37224885</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R, et al. Long COVID: mechanisms, risk factors and recovery. Exp Physiol. 2023;108:12&#x2013;27. doi: 10.1113/EP090802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP090802</ArticleId><ArticleId IdType="pmc">PMC10103775</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolton MJ, Chapman BP, Van Marwijk H. Low-dose naltrexone as a treatment for chronic fatigue syndrome. BMJ Case Rep. 2020;13:e232502. doi: 10.1136/bcr-2019-232502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2019-232502</ArticleId><ArticleId IdType="pmc">PMC6954765</ArticleId><ArticleId IdType="pubmed">31911410</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitt B, Tate AM, Gluck D, Rosenson RS, Goonewardena SN. Repurposing low-dose naltrexone for the prevention and treatment of immunothrombosis in COVID-19. Eur Heart J Cardiovasc Pharmacother. 2022;8:402&#x2013;405. doi: 10.1093/ehjcvp/pvac014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcvp/pvac014</ArticleId><ArticleId IdType="pmc">PMC8903502</ArticleId><ArticleId IdType="pubmed">35179184</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas K, Davies R, Sierk A. Conditional saddle-point configurations. Phys Rev C Nucl Phys. 1985;31:915&#x2013;922. doi: 10.1103/PhysRevC.31.915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1103/PhysRevC.31.915</ArticleId><ArticleId IdType="pubmed">9952602</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H, Peluso MJ, Rodgers K, Aberg JA, Patterson TF, Tamburro R, Baizer L, Goldman JD, Rouphael N, Deitchman A, Fine J, Fontelo P, Kim AY, Shaw G, Stratford J, Ceger P, Costantine MM, Fisher L, O'Brien L, et al. Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative. Front Immunol. 2023;9(14):1129459. doi: 10.3389/fimmu.2023.1129459.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1129459</ArticleId><ArticleId IdType="pmc">PMC10034329</ArticleId><ArticleId IdType="pubmed">36969241</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Yu C, Jing H, Wu X, Novakovic VA, Xie R, Shi J. Long COVID: The nature of thrombotic sequelae determines the necessity of early anticoagulation. Front Cell Infect Microbiol. 2022;5(12):861703. 10.3389/fcimb.2022.861703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9016198</ArticleId><ArticleId IdType="pubmed">35449732</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabani Z, Liu J, Su H. Vascular dysfunctions contribute to the long-term cognitive deficits following COVID-19. Biology (Basel) 2023;12:1106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10451811</ArticleId><ArticleId IdType="pubmed">37626992</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J, Astill S, Sivan M. The relationship between physical activity and long COVID: a cross-sectional study. Int J Environ Res Public Health. 2022;19:5093. doi: 10.3390/ijerph19095093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19095093</ArticleId><ArticleId IdType="pmc">PMC9105041</ArticleId><ArticleId IdType="pubmed">35564488</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen RH, Berg RMG. Vascular inflammation as a therapeutic target in COVID-19 "Long Haulers": HIITing the Spot? Front Cardiovasc Med. 2021;19(8):643626. 10.3389/fcvm.2021.643626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8044938</ArticleId><ArticleId IdType="pubmed">33869305</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller T, Riederer P, Kuhn W. Aminoadamantanes: from treatment of Parkinson&#x2019;s and Alzheimer&#x2019;s disease to symptom amelioration of long COVID-19 syndrome? Expert Rev Clin Pharmacol. 2023;16:101&#x2013;107. doi: 10.1080/17512433.2023.2176301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17512433.2023.2176301</ArticleId><ArticleId IdType="pubmed">36726198</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang P, Zhang L-Y, Tan Y-Y, Chen S-D. Links between COVID-19 and Parkinson&#x2019;s disease/Alzheimer&#x2019;s disease: reciprocal impacts, medical care strategies and underlying mechanisms. Transl Neurodegener. 2023;12:5. doi: 10.1186/s40035-023-00337-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-023-00337-1</ArticleId><ArticleId IdType="pmc">PMC9885419</ArticleId><ArticleId IdType="pubmed">36717892</ArticleId></ArticleIdList></Reference><Reference><Citation>Butterworth RF. Potential for the repurposing of adamantane antivirals for COVID-19. Drugs R D. 2021;21:267&#x2013;272. doi: 10.1007/s40268-021-00351-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40268-021-00351-6</ArticleId><ArticleId IdType="pmc">PMC8214976</ArticleId><ArticleId IdType="pubmed">34152583</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh T, Trudler D, Oh C-K, Lipton SA. Potential therapeutic use of the rosemary diterpene carnosic acid for Alzheimer&#x2019;s disease, Parkinson&#x2019;s disease, and long-COVID through NRF2 activation to counteract the NLRP3 inflammasome. Antioxidants. 2022;11:124. doi: 10.3390/antiox11010124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11010124</ArticleId><ArticleId IdType="pmc">PMC8772720</ArticleId><ArticleId IdType="pubmed">35052628</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutterwala FS, Haasken S, Cassel SL. Mechanism of NLRP3 inflammasome activation. Ann N Y Acad Sci. 2014;1319:82&#x2013;95. doi: 10.1111/nyas.12458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.12458</ArticleId><ArticleId IdType="pmc">PMC4074217</ArticleId><ArticleId IdType="pubmed">24840700</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xf6;lle M, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: efficacy of repeat immunoadsorption. J Clin Med. 2020;9:2443. doi: 10.3390/jcm9082443.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9082443</ArticleId><ArticleId IdType="pmc">PMC7465279</ArticleId><ArticleId IdType="pubmed">32751659</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchetti G, et al. Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study. J Neurol. 2022;269:3400&#x2013;3412. doi: 10.1007/s00415-022-11047-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11047-5</ArticleId><ArticleId IdType="pmc">PMC8898558</ArticleId><ArticleId IdType="pubmed">35249144</ArticleId></ArticleIdList></Reference><Reference><Citation>Antony AR, Haneef Z. Systematic review of EEG findings in 617 patients diagnosed with COVID-19. Seizure. 2020;83:234&#x2013;241. doi: 10.1016/j.seizure.2020.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2020.10.014</ArticleId><ArticleId IdType="pmc">PMC7569418</ArticleId><ArticleId IdType="pubmed">33121875</ArticleId></ArticleIdList></Reference><Reference><Citation>Haykal MA, Menkes DL. The clinical neurophysiology of COVID-19-direct infection, long-term sequelae and para-immunization responses: a literature review. Clin Neurophysiol Pract. 2023;8:3&#x2013;11. doi: 10.1016/j.cnp.2022.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cnp.2022.09.005</ArticleId><ArticleId IdType="pmc">PMC9574576</ArticleId><ArticleId IdType="pubmed">36275861</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayub N, et al. Clinical electroencephalography findings and considerations in hospitalized patients with coronavirus SARS-CoV-2. medRxiv. 2020 doi: 10.1101/2020.07.13.20152207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.13.20152207</ArticleId><ArticleId IdType="pmc">PMC8182395</ArticleId><ArticleId IdType="pubmed">34163546</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrescu A-M, Taussig D, Bouilleret V. Electroencephalogram (EEG) in COVID-19: a systematic retrospective study. Neurophysiol Clin. 2020;50:155&#x2013;165. doi: 10.1016/j.neucli.2020.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucli.2020.06.001</ArticleId><ArticleId IdType="pmc">PMC7315937</ArticleId><ArticleId IdType="pubmed">32653111</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrei Appelt P, et al. Changes in electrical brain activity and cognitive functions following mild to moderate COVID-19: a one-year prospective study after acute infection. Clin EEG Neurosci. 2022;53:543&#x2013;557. doi: 10.1177/15500594221103834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15500594221103834</ArticleId><ArticleId IdType="pmc">PMC9157278</ArticleId><ArticleId IdType="pubmed">35635280</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong J. EEG dynamics in patients with Alzheimer&#x2019;s disease. Clin Neurophysiol. 2004;115:1490&#x2013;1505. doi: 10.1016/j.clinph.2004.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2004.01.001</ArticleId><ArticleId IdType="pubmed">15203050</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Nuaimi AHH, Jammeh E, Sun L, Ifeachor E. Complexity measures for quantifying changes in electroencephalogram in Alzheimer&#x2019;s disease. Complexity. 2018;2018:1&#x2013;12. doi: 10.1155/2018/8915079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/8915079</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa JD, Brennan PM, Theodoratou E, Poon MTC, Purshouse K, Din FVN, Jin K, Mesa-Eguiagaray I, Dunlop MG, Hall PS, Cameron D, Wild SH, Sudlow CLM. Distinguishing between direct and indirect consequences of covid-19. BMJ. 2020;15(369):m2377. 10.1136/bmj.m2377.</Citation><ArticleIdList><ArticleId IdType="pubmed">32540857</ArticleId></ArticleIdList></Reference><Reference><Citation>Bungenberg J, et al. Long COVID-19: objectifying most self-reported neurological symptoms. Ann Clin Transl Neurol. 2022;9:141&#x2013;154. doi: 10.1002/acn3.51496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51496</ArticleId><ArticleId IdType="pmc">PMC8862437</ArticleId><ArticleId IdType="pubmed">35060361</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellgren L, et al. Brain MRI and neuropsychological findings at long-term follow-up after COVID-19 hospitalisation: an observational cohort study. BMJ Open. 2021;11:e055164. doi: 10.1136/bmjopen-2021-055164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-055164</ArticleId><ArticleId IdType="pmc">PMC8551746</ArticleId><ArticleId IdType="pubmed">34706965</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M, Sim S, Yang J, Kim M. Multivariate prediction of long COVID headache in adolescents using gray matter structural MRI features. Front Hum Neurosci. 2023;1(17):1202103. 10.3389/fnhum.2023.1202103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10267340</ArticleId><ArticleId IdType="pubmed">37323930</ArticleId></ArticleIdList></Reference><Reference><Citation>Klironomos S, et al. Nervous system involvement in coronavirus disease 2019: results from a retrospective consecutive neuroimaging cohort. Radiology. 2020;297:E324&#x2013;E334. doi: 10.1148/radiol.2020202791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020202791</ArticleId><ArticleId IdType="pmc">PMC7393954</ArticleId><ArticleId IdType="pubmed">32729812</ArticleId></ArticleIdList></Reference><Reference><Citation>Wardlaw JM, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822&#x2013;838. doi: 10.1016/S1474-4422(13)70124-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70124-8</ArticleId><ArticleId IdType="pmc">PMC3714437</ArticleId><ArticleId IdType="pubmed">23867200</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HW, Hong J, Jeon JC. Cerebral small vessel disease and Alzheimer's disease: A review. Front Neurol. 2020;25(11):927. 10.3389/fneur.2020.00927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7477392</ArticleId><ArticleId IdType="pubmed">32982937</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoamanesh A, Kwok CS, Benavente O. Cerebral microbleeds: histopathological correlation of neuroimaging. Cerebrovasc Dis. 2011;32:528&#x2013;534. doi: 10.1159/000331466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000331466</ArticleId><ArticleId IdType="pubmed">22104448</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghekar A, Kraut M, Elkins W, Troncoso J, Zonderman AB, Resnick SM, O'Brien RJ. Cerebral white matter disease is associated with Alzheimer pathology in a prospective cohort. Alzheimers Dement. 2012;8(5 Suppl):S71&#x2013;7. 10.1016/j.jalz.2012.04.006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3474974</ArticleId><ArticleId IdType="pubmed">23021624</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes A, Bertrand A, Lamari F, Colliot O, Routier A, Godefroy O, Etcharry-Bouyx F, Moreaud O, Pasquier F, Couratier P, Bennys K, Vercelletto M, Martinaud O, Laurent B, Pariente J, Puel M, Epelbaum S, Belliard S, Kaaouana T, et al. PHRC &#x201c;CAPP&#x201d; Study Group. Cerebral microbleeds and CSF Alzheimer biomarkers in primary progressive aphasias. Neurology. 2018;90(12):e1057&#x2013;65. 10.1212/WNL.0000000000005165.</Citation><ArticleIdList><ArticleId IdType="pubmed">29444966</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J, Msika E-F, Queneau M, Farid K, Paquet C. Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J Neurol. 2022;269:44&#x2013;46. doi: 10.1007/s00415-021-10655-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10655-x</ArticleId><ArticleId IdType="pmc">PMC8211714</ArticleId><ArticleId IdType="pubmed">34143277</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, et al. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Eur J Nucl Med Mol Imaging. 2021;48:3187&#x2013;3197. doi: 10.1007/s00259-021-05294-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05294-3</ArticleId><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Haseli S, Karimi-Galougahi M. Reply to &#x201c;MRI evaluation of the olfactory clefts in patients with SARS-CoV-2 infection revealed an unexpected mechanism for olfactory function loss&#x201d;. Acad Radiol. 2020;27:1192. doi: 10.1016/j.acra.2020.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acra.2020.05.025</ArticleId><ArticleId IdType="pmc">PMC7284249</ArticleId><ArticleId IdType="pubmed">32553280</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, et al. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18:e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022;9:815&#x2013;827. doi: 10.1016/S2215-0366(22)00260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>